Description

Mixtard 30HM Penfil: Managing Diabetes Mellitus

Ingredients

• Mixtard 30HM Penfil contains a combination of insulin human and insulin human isophane in the ratio of 30:70.
• Other ingredients include metacresol, glycerol, zinc chloride, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid, and water for injections.

Dosage

Mixtard 30HM Penfil should be administered subcutaneously. The dosage should be determined by a healthcare professional based on individual needs.

Indications

Mixtard 30HM Penfil is used to treat diabetes mellitus in adults, controlling blood sugar levels and regulating glucose metabolism in both type 1 and type 2 diabetes.

Contraindications

Do not use Mixtard 30HM Penfil if allergic to insulin or any ingredients. Avoid during hypoglycemia episodes or when adjustments can be made through diet or dosage changes.

Directions

• Inspect the cartridge before use.
• Administer subcutaneously, rotating injection sites.
• Follow healthcare provider’s instructions for proper administration.

Scientific Evidence

Studies show that Mixtard 30HM Penfil improves glycemic control and reduces long-term complications in diabetes. Research highlights its efficacy in achieving target HbA1c levels.

Additional Information

Regularly monitor blood glucose levels while using Mixtard 30HM Penfil. Adjust dosage as needed and seek medical advice for any concerns.

Pharmacology: Mixtard 30HM Penfil mimics natural insulin production, aiding glucose absorption for energy. It combines regular and isophane insulin for immediate and long-acting effects.

Comparative Effectiveness: Clinical trials show Mixtard 30HM Penfil is as effective as other insulin formulations in glycemic control with a lower risk of hypoglycemia, making it valuable for diabetes management.